GB Sciences Initiates Cannabis-based Therapy Clinical Trials …

According to Dr. Murphy, “Current research and development practices emphasize the importance of coordinated activity by industry, academia, and contract research organizations in the evaluation of innovative products, like those of GB Sciences. The process enhances program efficiency, facilitates the integration of the perspective of diverse stakeholders early in clinical development, and is a testament to GB Sciences’ strategic vision for the development of their portfolio of products. Worldwide is very pleased to be a contributor to that process, and the state-of-the-art technology which it reflects.”

Growblox Life Sciences LLC, a wholly owned subsidiary of GB Sciences, Inc., has filed three provisional patent applications to protect complex mixtures derived from the cannabis plant, which address twenty-six different disease-specific formulations within the Company’s intellectual property portfolio. On April 21, 2017, the Company held a Drug Development Strategy Meeting in Las Vegas, co-chaired by Dr. Murphy, and GB Sciences’ Chief

... read more at: http://www.prnewswire.com/news-releases/gb-sciences-initiates-cannabis-based-therapy-clinical-trials-consulting-services-agreement-with-worldwide-clinical-trials-inc-300482865.html

Leave a Reply

Your email address will not be published. Required fields are marked *